Dr. O’Connor brings deep experience in research and development, as well as commercial expertise in the biopharmaceutical industry.

Dr. O’Connor completed her fellowships in hematology, oncology, and AIDS oncology at the combined programs of the Massachusetts General, Brigham and Women’s, and Dana Farber Cancer Institute. She holds a B.A. in psychology with a biology focus from Yale University and an M.D. from Stanford University, underscoring her strong foundation as a physician scientist.

With a distinguished career spanning various leadership roles, Dr. O’Connor has been instrumental in developing and commercializing multiple mAb – based medicines. Currently, she is the Chief Medical Officer at Nurix Therapeutics to develop and deliver novel medicines for patients with cancer.